Zai Lab Limited
ZLABNASDAQHealthcare● Active
$16.48
$-0.14(-0.84%)
Market Cap$1.9B
P/E Ratio—
52W High$44.34
52W Low$15.96
Zai Lab Limited (ZLAB) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ZLAB · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.18B) | ($0.26B) | ($0.33B) | ($0.44B) | ($0.70B) |
| Depreciation & Amort. | $0.02B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.07B | $0.07B | $0.08B | $0.06B | $0.04B |
| Change in Working Capital | ($0.05B) | ($0.07B) | $0.04B | ($0.07B) | $0.02B |
| Net Cash from Operations | ($0.15B) | ($0.21B) | ($0.20B) | ($0.37B) | ($0.55B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.06B) | ($0.01B) | ($0.02B) | ($0.02B) |
| Purchases of Investments | ($0.01B) | ($0.33B) | ($0.13B) | ($0.26B) | ($0.45B) |
| Sales of Investments | $0.33B | $0.02B | $0.12B | $0.71B | $0.74B |
| Net Cash from Investing | $0.31B | ($0.38B) | ($0.01B) | $0.42B | $0.25B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.07B | $0.13B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.07B | $0.35B | ($0.01B) | ($0.00B) | $0.82B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.16B) | ($0.28B) | ($0.21B) | ($0.39B) | ($0.57B) |
| FCF Margin %(computed) | -34.53% | -69.27% | -77.49% | -182.58% | -393.72% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Zai Lab Limited data
About Zai Lab Limited (ZLAB) Cash Flow Statement
Zai Lab Limited generated operating cash flow of ($0.15B) and free cash flow of ($0.16B) for 2025 — a FCF margin of -34.53%. Capital expenditure was ($0.01B).
Frequently asked questions
ZLAB · 4 questionsZai Lab Limited generated free cash flow of ($0.16B) for 2025, up 42.5% year-over-year.
ZLAB free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10